Page last updated: 2024-10-26

etidronate and Asymmetric Diabetic Proximal Motor Neuropathy

etidronate has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research Excerpts

ExcerptRelevanceReference
" These findings suggest that etidronate in clinical dosage may have an antiatherogenic action, at least in type 2 diabetes, although its mechanisms remain to be elucidated."2.69Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes. ( Koshiyama, H; Minamikawa, J; Nakamura, Y; Tanaka, S, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koshiyama, H1
Nakamura, Y1
Tanaka, S1
Minamikawa, J1

Trials

1 trial available for etidronate and Asymmetric Diabetic Proximal Motor Neuropathy

ArticleYear
Decrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetes.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:8

    Topics: Bone Diseases, Metabolic; Carotid Arteries; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabet

2000